Biomarkers for Bioaccessibility and Bioavailability

Biomarkers are organic measures of a biological state. It is a characteristic that is quantitatively measured and assessed as an indicator of regular biological processes, pathological processes or pharmacological responses to a therapeutic intervention. Indicators can exist as quantitative or biochemical qualitative ones. They are also involved in the research related to drug development. Biomarkers are used to perform a clinical assessments Biomarkers may be used alone or in combination to evaluate the wellbeing or illness condition of a person. More proficient disclosure and utilization of biomarkers in the advancement of anti-diabetes medications will rely on propelling comprehension of the pathogenesis of diabetes and particularly its macrovascular intricacies.

  • Biological, functional and histological indicators
  • Qualitative biochemical markers
  • Quantitative biochemical markers
  • Biomarkers as health and disease predictors
  • Biomarkers in drug development.

Related Conference of Biomarkers for Bioaccessibility and Bioavailability

December 08-09, 2025

8th World Congress on Food and Nutrition

Rome, Italy
February 16-17, 2026

32nd International Conference on Clinical Nutrition

Paris, France
April 02-03, 2026

31st International Conference on Nutrition & Dietetics

Geneva, Switzerland
April 20-21, 2026

30th World Congress on Nutrition and Food Sciences

Amsterdam, Netherlands
April 23-24, 2026

8th World Summit on Health Nutrition

Paris, France
July 20-21, 2026

33rd European Nutrition and Dietetics Conference

Amsterdam, Netherlands
August 24-25, 2026

25th International Congress on Nutrition and Health

Paris, France
August 27-28, 2026

25th World Congress on Nutrition and Food Chemistry

Berlin, Germany

Biomarkers for Bioaccessibility and Bioavailability Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in